Main
>
ONCOLOGY (**)
>
Leukemia>Myeloid>Chronic ***
>
Treatment
>
Co: USA. A. Ponatinib
Co: USA. A. Ponatinib's subsections
Approved in: AU, CA, CH, EU, IL, US
Approved in: JP
Company/Licensor
Licensee in CH, EU, IL & RU:
Mechanism: BCR-ABL inhibitor
TradeMark
TradeMark Web-Site (USA)
UpDate: 2016. 09.28.
Co: USA. A. Ponatinib's products
This section has no products
Approved in: AU, CA, CH, EU, IL, US
Approved in: JP
Company/Licensor
Licensee in CH, EU, IL & RU:
Mechanism: BCR-ABL inhibitor
TradeMark
TradeMark Web-Site (USA)
UpDate: 2016. 09.28.